Company Information

ALPA LABORATORIES LTD.

NSE : ALPABSE : 532878ISIN CODE : INE385I01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE96.971.22 (+1.27 %)
PREV CLOSE ( ) 95.75
OPEN PRICE ( ) 97.67
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11276
TODAY'S LOW / HIGH ( )94.58 98.43
52 WK LOW / HIGH ( )55.1 115
NSE96.50-0.1 (-0.1 %)
PREV CLOSE( ) 96.60
OPEN PRICE ( ) 97.70
BID PRICE (QTY) 96.50 (79)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 66907
TODAY'S LOW / HIGH( ) 94.65 98.40
52 WK LOW / HIGH ( )55 115
ChairmanMahendra Singh Chawla
Managing DirectorParesh Chawla
Company SecretarySwati Bagh
Executive DirectorVitthal Kothana
Non Executive Independent DirectorDevendra Baheti
Sharad Chand Lunawat
Krishna Das Malani
Jyoti Jain
Sunil Valecha
Saket Baheti
Pratibha Lunawat
Whole Time DirectorPravin Shah
Incorporation Year : 1988

Registered Office :

Address : 33/2 Pigdamber,A B Road ,Rau Indore Dist,
Madhya Pradesh-453446 .

Phone : 0731-4294567

Email :  mail@alpalabs.in 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.